Dermatology
Latest News
Global melanoma incidence high and on the rise
The highest incidence and mortality rates of cutaneous melanoma are in wealthy nations, a new study shows.
Conference Coverage
For pemphigus, rituximab is first line, expert says
There are many advantages to suppressing disease activity “as soon as possible” after diagnosis, Dr. Erin Wei pointed out.
Conference Coverage
Dupilumab treats itch and clears lesions in prurigo nodularis patients
There are currently no Food and Drug Administration–approved systemic therapies for PN.
Conference Coverage
Skin reactions to first COVID-19 vaccine don’t justify forgoing second dose
“There are no serious adverse consequences from these cutaneous reactions,” said Dr. Esther Freeman.
From the Journals
Melanoma increasing, but is this overdiagnosis?
“Just like for other cancers ... there should be clear guidelines as to which populations to screen, as well as when to start and when to stop...
Conference Coverage
Cellulitis care costly from misdiagnosis, needless hospitalizations
“Cellulitis is misdiagnosed about one-third of the time, and that cost is very high,” reported Jennifer L. Adams, MD.
Conference Coverage
Global registry tracks COVID-19 outcomes in atopic dermatitis patients
Dupilumab monotherapy was associated with lower odds of hospitalizations compared with other therapies.
Conference Coverage
Clinical clarity grows about toenail disorder, experts report
Retronychia is usually a clinical diagnosis based on the presence of the increased bulk of the toenail when overlapping nails cannot be seen.
Conference Coverage
New trial data show hair growth in more alopecia areata patients
“Every time we add 16 weeks of data across hundreds of patients, we are making a huge step forward toward the goal of FDA approval for a...
Conference Coverage
Aluminum named allergen of the year
Reactions normally present as itchy nodules that can last for months and even years.
Conference Coverage
COVID-19 infection linked to risk of cutaneous autoimmune and vascular diseases
“Our theory is that the severe inflammatory nature of COVID-19 leads to a lot of internal organ damage and exposure of autoantigens in that...